NIH-funded research NIH-funded research

Evaluating cancer treatments for people living with HIV

Official title: AIDS Malignancy Consortium (AMC) - International Protocol Development Support

Funded at Icahn School of Medicine at Mount Sinai · NIH-11191802 · Data updated 2026-11-12

This study is looking at better ways to treat and prevent cancer for people living with HIV, and it offers a chance for patients to join clinical trials that could help improve their care.

More AIDS research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startDecember 1, 2024
Project endAugust 31, 2025
Funding year2025
Award (this year)$78,040
NIH project number3UM1CA121947-18S1
Project IDNIH-11191802 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation are individuals living with HIV who may also be at risk for or diagnosed with cancer.

Less likely to help

Patients who do not have HIV or are not at risk for cancer may not benefit from this research.

What this research studies

This research focuses on the AIDS Malignancy Consortium, which aims to assess and improve cancer treatment and prevention strategies for individuals living with HIV. The consortium operates across multiple international sites in sub-Saharan Africa and Latin America, conducting clinical trials to evaluate various interventions. By gathering expert scientific reviewers, the project will ensure rigorous peer review of clinical trials, enhancing the quality and effectiveness of the treatments being tested. Patients may have the opportunity to participate in these trials, contributing to advancements in care.

Why it matters

Potential benefit: If successful, this research could lead to improved cancer treatment options for patients living with HIV.

How similar studies have gone: Previous research has shown success in evaluating cancer treatments for HIV-positive populations, indicating a promising approach.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Sparano, Joseph a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.